These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14716348)

  • 1. Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GVHD and receiving glucocorticoid therapy.
    Hovi L; Saarinen-Pihkala UM; Taskinen M; Wikström AM; Dunkel L
    Bone Marrow Transplant; 2004 Mar; 33(5):503-8. PubMed ID: 14716348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired androgen production in female adolescents and young adults after total body irradiation prior to BMT in childhood.
    Hovi L; Tapanainen P; Saarinen-Pihkala UM; Siimes MA
    Bone Marrow Transplant; 1997 Oct; 20(7):561-5. PubMed ID: 9337057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L; Selleri C; Rosa GD; Pagano L; Orio F; Lombardi G; Rotoli B; Colao A
    Cancer; 2002 Sep; 95(5):1076-84. PubMed ID: 12209694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens in women after allogeneic hematopoietic cell transplantation: impact of chronic GvHD and glucocorticoid therapy.
    Björk Y; Smith Knutsson E; Ankarberg-Lindgren C; Broman AK; Andersson I; Björkman L; Magnusson J; Bergmark K; Anderson H; Andersson PO; Brune M
    Bone Marrow Transplant; 2017 Mar; 52(3):431-437. PubMed ID: 27941768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ cell damage and Leydig cell insufficiency in recipients of nonmyeloablative transplantation for haematological malignancies.
    Kyriacou C; Kottaridis PD; Eliahoo J; McKeag N; Bomford J; McGarrigle HH; Linch DC; Mackinnon S; Chatterjee R
    Bone Marrow Transplant; 2003 Jan; 31(1):45-50. PubMed ID: 12621506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
    Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
    Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens.
    Kamenicky P; Houdoin L; Ferlicot S; Salenave S; Brailly S; Droupy S; Meduri G; Sasano H; Suzuki T; Young J; Chanson P
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):778-88. PubMed ID: 17408424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum androgen levels in women with premature ovarian failure.
    Benetti-Pinto CL; Bedone AJ; Magna LA
    Fertil Steril; 2005 Feb; 83(2):508-10. PubMed ID: 15705407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations.
    Dupuis CC; Storr HL; Perry LA; Ho JT; Ahmed L; Ong KK; Dunger DB; Monson JP; Grossman AB; Besser GM; Savage MO
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):838-43. PubMed ID: 17437509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting gonadal function after bone marrow transplantation during childhood.
    Couto-Silva AC; Trivin C; Thibaud E; Esperou H; Michon J; Brauner R
    Bone Marrow Transplant; 2001 Jul; 28(1):67-75. PubMed ID: 11498747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acne and serum androgens during puberty.
    Lee PA
    Arch Dermatol; 1976 Apr; 112(4):482-4. PubMed ID: 131513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal function following bone marrow transplantation.
    Grönroos MH; Bolme P; Winiarski J; Berg UB
    Bone Marrow Transplant; 2007 Jun; 39(11):717-23. PubMed ID: 17401393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failure.
    Teinturier C; Hartmann O; Valteau-Couanet D; Benhamou E; Bougneres PF
    Bone Marrow Transplant; 1998 Nov; 22(10):989-94. PubMed ID: 9849696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological features in patients with hepatic graft-versus-host disease.
    Chiba T; Yokosuka O; Goto S; Fukai K; Imazeki F; Kohno Y; Nishimura M; Saito Y; Saisho H
    Hepatogastroenterology; 2005; 52(66):1849-53. PubMed ID: 16334791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles.
    Orvieto R; Yulzari-Roll V; La Marca A; Ashkenazi J; Fisch B
    Gynecol Endocrinol; 2005 Oct; 21(4):218-22. PubMed ID: 16316843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female pattern hair loss may be triggered by low oestrogen to androgen ratio.
    Riedel-Baima B; Riedel A
    Endocr Regul; 2008 Mar; 42(1):13-6. PubMed ID: 18333699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Christodoulakos G; Lambrinoudaki I; Panoulis C; Sioulas V; Rizos D; Caramalis G; Botsis D; Creatsas G
    Maturitas; 2005 Apr; 50(4):321-30. PubMed ID: 15780533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma androgen concentrations and risk of incident ovarian cancer.
    Tworoger SS; Lee IM; Buring JE; Hankinson SE
    Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.